2-(2-羟基苯基)-4H-1,3-苯并恶嗪-4-酮，CAS 登记号 1218-69-5，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2-(2-羟基苯基)-4H-1,3-苯并恶嗪-4-酮 的 CAS 号：1218-69-5，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2-(2-HYDROXYPHENYL)-4H-1,3-BENZOXAZIN-4-ONE · CAS 1218-69-5 · C14H9NO3. UNII FQ3SS25RJ9.
| CAS Registry Number | 1218-69-5 |
|---|---|
| PubChem CID | 135685723 |
| Molecular formula | C14H9NO3 |
| IUPAC name | 2-(2-hydroxyphenyl)-1,3-benzoxazin-4-one |
| UNII (FDA) | FQ3SS25RJ9 |
| Molecular Weight | 239.23 |
|---|---|
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 239.058243149 |
| Monoisotopic Mass | 239.058243149 |
| Topological Polar Surface Area | 58.9 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| GHS notification summary | 25% (1 / 4) |
|---|
| GHS notification summary | 25% (1 / 4) |
|---|---|
| Reported hazard statements | H302 (25%), H315 (25%), H317 (50%), H319 (25%), H335 (25%), H410 (50%) |
This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.
H302 (25%): Harmful if swallowed [Warning Acute toxicity, oral]
1218-69-5; 2-(2-hydroxyphenyl)-4H-1,3-benzoxazin-4-one; 4H-1,3-Benzoxazin-4-one, 2-(2-hydroxyphenyl)-; FQ3SS25RJ9; DEFERASIROX IMPURITY B [EP IMPURITY]; DEFERASIROX IMPURITY B (EP IMPURITY); RefChem:197563; 2-(2-Hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one; Deferasirox Benzoxazin Impurity; MFCD02234511; 2-(2-HYDROXYPHENYL)-1,3-BENZOXAZIN-4-ONE; 2-(2-Hydroxyphenyl)benz[e][1,3]oxazin-4-one; AKOS015909621; Deferasirox Impurity 4; 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazine-4-one; 2-(2-hydroxyphenyl) benz [e] [1, 3] oxazin-4-one
CAS 1218-69-5; molecular formula C14H9NO3; molecular weight — g/mol.
1218-69-5, 2-(2-hydroxyphenyl)-4H-1,3-benzoxazin-4-one, 4H-1,3-Benzoxazin-4-one, 2-(2-hydroxyphenyl)-, FQ3SS25RJ9, DEFERASIROX IMPURITY B [EP IMPURITY], DEFERASIROX IMPURITY B (EP IMPURITY).
25% of GHS notifications report no hazard classification (1 of 4).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.